An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2025 Jan-.
Top results in this bookTable of Contents
GeneReviews® [Internet].
Adam MP, Bick S, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2026.
Endotext [Internet].
Feingold KR, Adler RA, Ahmed SF, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
Clinical Review Report: Insulin Degludec (Tresiba): (Novo Nordisk Canada Inc): Indication: For once-daily treatment of adults with diabetes mellitus to improve glycemic control [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Dec.
Improving management of type 1 diabetes in the UK: the Dose Adjustment For Normal Eating (DAFNE) programme as a research test-bed. A mixed-method analysis of the barriers to and facilitators of successful diabetes self-management, a health economic analysis, a cluster randomised controlled trial of different models of delivery of an educational intervention and the potential of insulin pumps and additional educator input to improve outcomes.
Heller S, Lawton J, Amiel S, et al.
Southampton (UK): NIHR Journals Library; 2014 Dec. (Programme Grants for Applied Research, No. 2.5.)
Clinical Review Report: Glucagon Nasal Powder (Baqsimi): (Eli Lilly Canada Inc): Indication: For the treatment of severe hypoglycemic reactions which may occur in the management of insulin treated patients with diabetes mellitus, when impaired consciousness precludes oral carbohydrates [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Mar.
Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R, Corro Ramos I, Birnie R, et al.
Southampton (UK): NIHR Journals Library; 2016 Feb. (Health Technology Assessment, No. 20.17.)
A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
Heller S, White D, Lee E, et al.
Southampton (UK): NIHR Journals Library; 2017 Apr. (Health Technology Assessment, No. 21.20.)
Glycaemic control in labour with diabetes: GILD, a scoping study.
Jones NW, Mitchell EJ, Walker KF, et al.
Southampton (UK): National Institute for Health and Care Research; 2025 Aug. (Health Technology Assessment, No. 29.41.)
New Drugs for Type 2 Diabetes: Second-Line Therapy — Science Report [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Sep. (CADTH Therapeutic Review, No. 4.1b.)
Diabetes Medications for Adults With Type 2 Diabetes: An Update [Internet].
Bolen S, Tseng E, Hutfless S, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Apr. (Comparative Effectiveness Reviews, No. 173.)
Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation.
Johnston R, Uthman O, Cummins E, et al.
Southampton (UK): NIHR Journals Library; 2017 Jan. (Health Technology Assessment, No. 21.2.)
Pharmacoeconomic Review Report: Insulin Degludec (Tresiba): (Novo Nordisk Canada Inc.): Indication: For once-daily treatment of adults with diabetes mellitus to improve glycemic control [Internet].
Predictors and Consequences of Severe Hypoglycemia in Adults with Diabetes - A Systematic Review of the Evidence [Internet].
Bloomfield HE, Greer N, Newman D, et al.
Washington (DC): Department of Veterans Affairs (US); 2012 Apr.
Clinical Review Report: Lixisenatide (Adlyxine): (Sanofi-aventis Canada Inc.): Indication: As an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus in combination with metformin, a sulfonylurea (alone or with metformin), pioglitazone (alone or with metformin), a basal insulin (alone or with metformin), when the therapy listed above does not provide adequate glycemic control [Internet].
Triheptanoin (Dojolvi): CADTH Reimbursement Review: Therapeutic area: Long-chain fatty acid oxidation disorders [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Apr.
Diabetes in America [Internet].
Lawrence JM, Casagrande SS, Herman WH, et al., editors.
Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); 2023-.
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.
Asgharzadeh A, Patel M, Connock M, et al.
Southampton (UK): National Institute for Health and Care Research; 2024 Dec. (Health Technology Assessment, No. 28.80.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on